Actinium Pharmaceuticals Inc
ATNM1.655USD
+0.045+2.80%
收盤 08/04, 16:00（美東）報價延遲15分鐘
51.63M總市值
虧損本益比TTM
關於 Actinium Pharmaceuticals Inc 公司
Actinium Pharmaceuticals, Inc. 是一家後期生物製藥公司。該公司致力於開發靶向放射療法，以提高現有腫瘤療法失敗患者的生存率。該公司的先進候選藥物包括 Iomab-B（pre-BLA 和 MAA (EU)）和 Actimab-A。Iomab-B 是骨髓移植前的誘導和調理劑。Actimab-A 是一種治療劑，已證明有潛力延長復發和難治性急性髓性白血病患者的生存期。該公司專注於用於其他血癌的先進 Iomab-B 和下一代調理候選藥物 Iomab-ACT，以改善細胞和基因治療結果。該公司擁有專利申請，包括與在迴旋加速器中製造同位素 Ac-225 相關的多項專利。Actinium-225 是一種強效的阿爾法粒子發射體，具有高線性能量轉移能力，能夠通過 DNA 雙鏈斷裂殺死目標癌細胞。
公司簡介
公司代碼ATNM
公司名稱Actinium Pharmaceuticals Inc
上市日期Mar 26, 2014
CEOMr. Sandesh (Andes) Seth
員工數量37
證券類型Ordinary Share
年結日Mar 26
公司地址100 Park Ave., 23Rd Floor
城市NEW YORK
上市交易所NYSE American Consolidated
國家United States of America
郵編10017
電話16466773870
網址https://www.actiniumpharma.com/
公司代碼ATNM
上市日期Mar 26, 2014
CEOMr. Sandesh (Andes) Seth
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Sandesh (Andes) Seth
Mr. Sandesh (Andes) Seth
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
5.38K
--
Dr. Ajit S. Shetty, Ph.D.
Dr. Ajit S. Shetty, Ph.D.
Independent Director
Independent Director
757.00
--
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Independent Director
Independent Director
316.00
--
Mr. Steve O'Loughlin
Mr. Steve O'Loughlin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. June S. Almenoff, M.D., Ph.D.
Dr. June S. Almenoff, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Jeffrey W. Chell, M.D.
Dr. Jeffrey W. Chell, M.D.
Independent Director
Independent Director
--
--
Dr. C. David Nicholson, Ph.D.
Dr. C. David Nicholson, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Sandesh (Andes) Seth
Mr. Sandesh (Andes) Seth
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
5.38K
--
Dr. Ajit S. Shetty, Ph.D.
Dr. Ajit S. Shetty, Ph.D.
Independent Director
Independent Director
757.00
--
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Independent Director
Independent Director
316.00
--
Mr. Steve O'Loughlin
Mr. Steve O'Loughlin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. June S. Almenoff, M.D., Ph.D.
Dr. June S. Almenoff, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Jeffrey W. Chell, M.D.
Dr. Jeffrey W. Chell, M.D.
Independent Director
Independent Director
--
--
收入明細
FY2024
暫無數據
地區USD
名稱
營收
佔比
United States
0.00
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月27日 週二
更新時間: 5月27日 週二
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
5.73%
The Vanguard Group, Inc.
4.40%
District 2 Capital LP
2.47%
Geode Capital Management, L.L.C.
2.28%
State Street Global Advisors (US)
2.07%
Other
83.05%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
5.73%
The Vanguard Group, Inc.
4.40%
District 2 Capital LP
2.47%
Geode Capital Management, L.L.C.
2.28%
State Street Global Advisors (US)
2.07%
Other
83.05%
股東類型
持股股東
佔比
Investment Advisor
14.48%
Investment Advisor/Hedge Fund
10.07%
Hedge Fund
3.43%
Individual Investor
1.79%
Research Firm
0.76%
Pension Fund
0.14%
Bank and Trust
0.10%
Family Office
0.08%
Other
69.14%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
190
9.60M
30.78%
-2.97M
2025Q1
201
9.91M
31.75%
-2.62M
2024Q4
203
9.81M
31.44%
-2.78M
2024Q3
193
10.48M
34.47%
-136.85K
2024Q2
179
9.47M
32.33%
-512.57K
2024Q1
170
8.96M
30.96%
+85.09K
2023Q4
170
7.87M
28.74%
-1.58M
2023Q3
171
7.67M
28.80%
-1.27M
2023Q2
165
7.78M
29.70%
+701.53K
2023Q1
138
6.95M
27.77%
+572.16K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.79M
5.73%
-28.99K
-1.59%
Mar 31, 2025
The Vanguard Group, Inc.
1.57M
5.04%
-45.61K
-2.82%
Mar 31, 2025
District 2 Capital LP
769.45K
2.47%
-56.98K
-6.89%
Nov 08, 2024
Geode Capital Management, L.L.C.
711.80K
2.28%
+23.95K
+3.48%
Mar 31, 2025
State Street Global Advisors (US)
645.22K
2.07%
+24.14K
+3.89%
Mar 31, 2025
Acadian Asset Management LLC
504.04K
1.62%
+4.78K
+0.96%
Mar 31, 2025
Bigger (Michael)
450.17K
1.44%
-27.50K
-5.76%
Nov 08, 2024
UBS Financial Services, Inc.
396.14K
1.27%
+307.32K
+346.02%
Mar 31, 2025
Bigger Capital Funds, LP
235.69K
0.76%
-205.41K
-46.57%
Nov 08, 2024
Los Angeles Capital Management LLC
233.25K
0.75%
+19.30K
+9.02%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
iShares Micro-Cap ETF
佔比0.01%
Global X Russell 2000 Covered Call ETF
佔比0%
ProShares Hedge Replication ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Russell 2000 Value ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
公告日期
類型
比率
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
